NEXT GENERATION OF RECONSTRUCTIVE SURGERY Perfectly

NEXT GENERATION OF
RECONSTRUCTIVE
SURGERY
Perfectly YOU, in all sizes
forever
THE first company to offer
 Permanent results in grafted breast reconstsructions
 Fat grafting also for B and C cup-sizes of breasts
 A clinically validated method for the cosmetological market
 Cultured endogenous fat-derrived hMCs, BoobieCells for the
cosmetological market
Market*
Nordic
There are aprox . 11000 breast surgeries performed each year (DK4000, SE5000,
NO1000, FI1000)
Europe
Aprox. 100.000
US
Every 4th woman will at one point in life do a breast reconstruction either due to
clinical reasons or for cosmetical reasons only.
*. The grafting is still a fairly small part, due to the poor success rate
Current split is approximately 90%implant 10%grafting .
need for additional surgery
Business
Currently a breast enlargement costs 3-4.000 Eur.

Current market for breast surgery in Europe is approximately
30-40.000.000 Euro=> 3-4.000.000 Euro is grafting
Boobicell will address the top segment of this market.
A reconstruction w “BoobieCells” will cost twice as much as the current
procedure, as one procedure is sufficient
3-4 000 Euro ,for one set of approved BoobieCells
We are expecting to reach a marketshare of 3 % on the existing
market(in Europe) over a 2 year period.
This will give; 0,03 x 100 000= 3000 treatments x 3.000Euro
9.000.000Euro
Where are we..
Clinical study at the Rikshospitalet
March 2015;
Randomied placebo-controlledt study
blinded for all participants.
1.
13 healthy participnats
2.
Small liposcuction from
abdomen
3.
Stemcells extracted and
expanded in lab
4.
Surgery w fat & stemcells
What do we already know..
Survival transplanted fat tissue
after 4 months.
Without stemcells: 16 %
With stemcells: 81 %
This is our product
1,2 billion BoobieCells
This is our team
Dusan Raicevic
dusan@boobiecell.com
Dr Raimund Strehl
Raimund @boobiecell.com